Pages that link to "Q64590755"
Jump to navigation
Jump to search
The following pages link to J. Timothy Greenamyre (Q64590755):
Displaying 50 items.
- LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson's disease (Q23923990) (← links)
- Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models (Q26863375) (← links)
- Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease (Q27302176) (← links)
- Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease (Q28292922) (← links)
- The role of glutamate in neurotransmission and in neurologic disease (Q28302899) (← links)
- A frameshift mitochondrial complex I gene mutation in a patient with dystonia and cataracts: is the mutation pathogenic? (Q28364132) (← links)
- Immunocytochemical characterization of the mitochondrially encoded ND1 subunit of complex I (NADH : ubiquinone oxidoreductase) in rat brain (Q28565020) (← links)
- Chronic systemic pesticide exposure reproduces features of Parkinson's disease (Q29614763) (← links)
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials (Q30278084) (← links)
- N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking (Q30486372) (← links)
- A highly reproducible rotenone model of Parkinson's disease (Q30490799) (← links)
- Hypokinesia and reduced dopamine levels in zebrafish lacking β- and γ1-synucleins (Q30504583) (← links)
- Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro. (Q30537879) (← links)
- Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease (Q30573637) (← links)
- Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism (Q31141329) (← links)
- A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease (Q32062079) (← links)
- Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents. (Q33544048) (← links)
- Neurotoxic in vivo models of Parkinson's disease recent advances. (Q33708283) (← links)
- Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors. (Q33899839) (← links)
- Mechanism of toxicity in rotenone models of Parkinson's disease (Q33974271) (← links)
- Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication (Q33990927) (← links)
- Mitochondrial dysfunction in Parkinson's disease. (Q34034579) (← links)
- Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease (Q34090228) (← links)
- Transient muscarinic and glutamatergic stimulation of neural stem cells triggers acute and persistent changes in differentiation (Q34122870) (← links)
- Environment, mitochondria, and Parkinson's disease (Q34133031) (← links)
- Glutamatergic influences on the basal ganglia. (Q34221541) (← links)
- Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease (Q34342939) (← links)
- Pathogenesis of Parkinson's disease (Q34379357) (← links)
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives (Q34426072) (← links)
- Complex I and Parkinson's disease (Q34499041) (← links)
- Autonomic insufficiency in pupillary and cardiovascular systems in Parkinson's disease. (Q34556515) (← links)
- The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys (Q34566620) (← links)
- Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra (Q34572037) (← links)
- Animal models of Parkinson's disease. (Q34596189) (← links)
- Mitochondrial DNA damage as a peripheral biomarker for mitochondrial toxin exposure in rats (Q34605975) (← links)
- A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease (Q34658144) (← links)
- Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. (Q34806527) (← links)
- Gene–Environment Interactions in Parkinson's Disease: The Importance of Animal Modeling (Q34898429) (← links)
- Mechanistic approaches to Parkinson's disease pathogenesis. (Q34984539) (← links)
- PCR based determination of mitochondrial DNA copy number in multiple species (Q35034159) (← links)
- Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease. (Q35058875) (← links)
- Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults (Q35102002) (← links)
- Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line (Q35133165) (← links)
- The rotenone model of Parkinson's disease: genes, environment and mitochondria (Q35198060) (← links)
- Alternative excitotoxic hypotheses (Q35227246) (← links)
- The role of environmental exposures in neurodegeneration and neurodegenerative diseases (Q35551001) (← links)
- Toxin models of mitochondrial dysfunction in Parkinson's disease. (Q35799141) (← links)
- Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates (Q35885612) (← links)
- Ubiquitin-proteasome system and Parkinson's diseases (Q35998400) (← links)
- shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model (Q36040166) (← links)